Associated Papers
Association between APOA5 polymorphisms and susceptibility to metabolic syndrome: a systematic review and meta-analysis.
Mozafari S et al.
Bmc Genomics, 2024
38867151 (PubMed )
Supplement: 12864_2024_10493_MOESM1_ESM.docx
Comparison of the structure-function properties of wild-type human apoA-V and a C-terminal truncation associated with elevated plasma triglycerides.
Stankov S et al.
Medrxiv : the Preprint Server for Health Sciences, 2023
A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug.
Bogari NM et al.
Bmc Cardiovascular Disorders, 2019
The "T" allele of apolipoprotein A5 rs2075291 is significantly associated with higher total cholesterol and triglyceride and lower high-density lipoprotein cholesterol levels in Asians: a meta-analysis.
Qian X et al.
Nutrition Research (new York, N.y.), 2018
Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism.
Forte TM et al.
Current Drug Targets, 2015
Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291).
Sharma V et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2014
Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population.
Matsunaga A et al.
Circulation Journal : Official Journal of the Japanese Circulation Society, 2007
Select a paper to view details